Andy Ewalt > Freshfields Bruckhaus Deringer LLP > Washington DC, United States > Lawyer Profile
Freshfields Bruckhaus Deringer LLP Offices
700 13TH STREET NW
10TH FLOOR
WASHINGTON, DC 20005
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Andy Ewalt
Work Department
Antitrust, Competition, and Trade
Position
Partner
Career
Andy focuses on US antitrust litigation and investigations, including both civil and criminal matters.
Before joining Freshfields, Andy served for more than a decade at the Antitrust Division of the US Department of Justice, gaining significant experience investigating and litigating civil and criminal antitrust matters involving a wide variety of industries. As counsel to the Director of Litigation from 2016 to 2018, he worked closely with DOJ leadership in supervising the Division’s civil litigation program during a period of unparalleled activity and success.
Top Tier Firm Rankings
- M&A/corporate and commercial > Corporate governance
- Dispute resolution > International arbitration
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Tax > Financial products
Firm Rankings
- Dispute resolution > International litigation
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- Tax > US taxes: non-contentious
- International trade > CFIUS
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > General commercial disputes
- Media, technology and telecoms > Technology transactions
- Healthcare > Life sciences
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism